Association between glucagon-like peptide 1 receptor agonist (GLP1-RA) and sodium glucose co-transporter 2 inhibitor (SGLT2i) use and COVID-19 outcomes: A national retrospective cohort study First published 01/11/2020 Last updated 23/04/2024 EU PAS number:EUPAS37860 Study Planned